Nicox S.A.

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
    • Vaccines
    • OTC, Consumer
  • Medical Devices
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
    • Chemistry, Immunoassay
  • Biotechnology

Other Names/Subsidiaries

  • Laboratoires Doliage
  • Eupharmed srl
  • Aciex Therapeutics, Inc.
  • AVEye Biotechnologie GmbH
  • AVEye Biotechnologie
  • Les Laboratoires Doliage
  • Nicox Ophthalmics (formerly Aciex Therapeutics)
See more in Biomedtracker

Latest on Nicox S.A.

Scrip

Deal Watch: Novartis Hopes To Ace Inflammatory Disease With Matchpoint Tie-Up

 
• By Joseph Haas, Lisa Takagi, and Manas Mishra

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis, Matchpoint Will Seek Out Oral

Scrip

Deal Watch: Shionogi Will Market Nxera’s Insomnia Drug In Japan

 
• By Joseph Haas, Lisa Takagi, Vibha Ravi, and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Shionogi Gets Daridorexant’s Japanese D

Scrip

Asia Deal Watch: Ono Inks Partnerships With Switzerland’s Numab, US Biotech Shattuck

 
• By Joseph Haas and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Ono, Numab Partner On Macrophage P

Scrip

Nicox’s NCX 470 Hits Phase III Endpoint In Glaucoma But Misses Superiority

 
• By Joseph Haas

Nicox S.A. posted mostly favorable Phase III data from the first of two pivotal trials for its glaucoma/ocular hypertension eye drop NCX 470, but missed demonstrating superiority versus a comparator